Side effects of drugs annual. Volume 39, A worldwide yearly survey of new data in adverse drug reactions /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ray, Sidhartha D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam, Netherlands ; Oxford, England ; Cambridge, Massachusetts : Elsevier, 2017.
Temas:
Drugs > Side effects.
Drug-Related Side Effects and Adverse Reactions
M�edicaments > Effets secondaires.
MEDICAL > Pharmacology.
Drugs > Side effects
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
  • Copyright
  • Contributors
  • Contents
  • Preface
  • Special Reviews in SEDA 39
  • Table of Essays, Annuals 1�a#x80;#x93;38
  • Abbreviations
  • ADRs, ADEs and SEDs: A Bird's Eye View
  • Introduction
  • Analysis of ADEs, ADRs, Side Effects and Toxicity
  • Terminology
  • EIDOS
  • DoTS
  • WHO Classification
  • References on Adverse Drug Reactions
  • Pharmacogenomics Considerations
  • Enzymes and Transporters
  • Human Leukocyte Antigens (HLA)
  • Genetic Testing Technology
  • ConclusionReferences
  • Immunological Reactions
  • Type I Reactions (IgE-Mediated Anaphylaxis; Immediate Hypersensitivity)
  • Type II Reactions (Cytotoxic Reactions)
  • Type III Reactions (Immune Complex Reactions)
  • Type IV Reactions (Cell-Mediated or Delayed Hypersensitivity Reactions)
  • Other Types of Reactions
  • References
  • Analysis of Toxicological Reactions
  • Potentiation Reactions
  • Examples:
  • Synergistic Effect
  • Additive Effect
  • Examples:
  • Antagonistic Effects
  • Examples:
  • References
  • Grades of Adverse Drug Reactions
  • SEDA-38, 1]Organs and Systems
  • Cardiovascular
  • Reproductive Systems
  • Skin
  • Drug�a#x80;#x93;Drug Interaction
  • Methylxanthines
  • Caffeine [SEDA-32, 14; SEDA-33, 11; SEDA-34, 6; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Organs and Systems
  • Cardiovascular
  • Selective Norepinephrine Reuptake Inhibitors Atomoxetine [SEDA-34, 4; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Organ and Systems
  • Drug-Drug Interactions
  • Vigilance Promoting Drugs
  • Modafinil and Armodafinil [SEDA-34, 6; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Organs and Systems
  • PsychiatricDrugs That Suppress Appetite [SEDA-34, 8; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Phentermine [SEDA-34, 8; SEDA-36, 1, SEDA-37, 1; SEDA-38, 1]
  • Organs and Systems
  • Gastrointestinal
  • Parasympathomimetics [SEDA-34, 9, SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Donepezil [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Organ and Systems
  • Psychiatric
  • Memantine [SEDA-34, 1]
  • Organ and Systems
  • Cardiovascular
  • Rivastigmine [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1]
  • Organ and Systems
  • Skin
  • References

Ejemplares similares